Caspian Unveils KO-7246 Preclinical Diabetes Data at EASD
SAN DIEGO — September 29, 2026 Caspian Therapeutics and Kura Oncology announced new preclinical data for KO-7246, an investigational,...
Type 1 Diabetes
Advertisement
Revvity Launches CE-IVDR T1D Early Detection Solution
WALTHAM, Mass. — September 24, 2026 Revvity, Inc. announced the launch of the GSP® T1D 3plex kit, a fully...
Kura Oncology launches Caspian Therapeutics with $50M financing
SAN DIEGO — September 9, 2026 Kura Oncology, Inc. announced the launch of Caspian Therapeutics, Inc., a separately financed...
Sernova and Seraxis Merge to Create BetaNova Biotherapeutics
TORONTO, Canada and GERMANTOWN, Maryland — September 8, 2026 Sernova Biotherapeutics Inc. and Seraxis Holdings, Inc. announced a definitive...
Genprex Advances Diabetes Gene Therapy Manufacturing Scale-Up
AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...
Advertisements
FibroBiologics Wins U.S. Patent for Islet Transplant Therapy
HOUSTON, Texas, August 11, 2026 FibroBiologics, Inc. announced that the United States Patent and Trademark Office (USPTO) has issued...
Sana Reports Long-Term Type 1 Diabetes Data
SEATTLE, July 13, 2026 Sana Biotechnology announced the publication of long-term clinical findings in The New England Journal of...
Century Therapeutics Showcases CNTY-813 at EASD
PHILADELPHIA, July 9, 2026 Century Therapeutics announced that its CNTY-813 preclinical research has been selected for oral presentations at...
Insulet Expands Omnipod 5 Diabetes Care in Spain
ACTON, Mass., July 6, 2026 Insulet Corporation announced the commercial launch of its Omnipod® 5 Automated Insulin Delivery System...
Sana Biotechnology to Present UP421 Clinical Data at EASD 2026
SEATTLE, July 1, 2026 Sana Biotechnology, Inc. announced that new clinical data from a first-in-human investigator-sponsored study evaluating UP421,...
Advertisement
